Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 6 Stomach Neoplasms 5 Sarcoma 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Pancreatectomy 1 Ovarian Neoplasms 1 Neoplasms 1 Motor Activity 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Heart Defects, Congenital 1 Gynecologic Surgical Procedures 1 Gynecologic Cancer 1 Gastrointestinal Neoplasms 1 Frailty 1 Coma 1 Colonic Neoplasms 1 Cerebrovascular Disorders 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Brain Injuries, Traumatic 1

Interventions

Trastuzumab 628 Paclitaxel 577 Cyclophosphamide 555 Docetaxel 485 Capecitabine 402 Letrozole 376 Fulvestrant 327 Doxorubicin 294 Carboplatin 279 Tamoxifen 275 Anastrozole 243 exemestane 228 Radiotherapy 218 Epirubicin 211 Bevacizumab 196 palbociclib 189 pertuzumab 186 Vinorelbine 167 Lapatinib 167 Gemcitabine 166 pembrolizumab 162 Surveys and Questionnaires 139 Exercise 136 Magnetic Resonance Spectroscopy 123 Fluorouracil 119 Blood Specimen Collection 118 eribulin 117 Albumin-Bound Paclitaxel 117 Drug Therapy 111 130-nm albumin-bound paclitaxel 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Enhanced Recovery After Surgery × Clear all

NCT05363189 2025-07-03

BestDIEP

Vastra Gotaland Region

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡